abstract |
The present invention relates to a compound of formula I: < EMI ID = 6.1 > or a pharmaceutically acceptable salt thereof, (I) In this formula, R1 to R3, X and Y are as defined in the specification and claims. The compounds of formula I may be used as medicaments for the treatment and / or prevention of inflammatory diseases or disorders in mammals, especially as transient receptor potential (TRP) channel antagonists. |